Article
Evolution of antibody immunity to SARS-CoV-2.
Nature - 1 Mar 2021
Gaebler Christian, Wang Zijun, Lorenzi Julio C C, Muecksch Frauke, Finkin Shlomo, Tokuyama Minami, Cho Alice, Jankovic Mila, Schaefer-Babajew Dennis, Oliveira Thiago Y, Cipolla Melissa, Viant Charlotte, Barnes Christopher O, Bram Yaron, Breton Gaëlle, Hägglöf Thomas, Mendoza Pilar, Hurley Arlene, Turroja Martina, Gordon Kristie, Millard Katrina G, Ramos Victor, Schmidt Fabian, Weisblum Yiska, Jha Divya, Tankelevich Michael, Martinez-Delgado Gustavo, Yee Jim, Patel Roshni, Dizon Juan, Unson-O'Brien Cecille, Shimeliovich Irina, Robbiani Davide F, Zhao Zhen, Gazumyan Anna, Schwartz Robert E, Hatziioannou Theodora, Bjorkman Pamela J, Mehandru Saurabh, Bieniasz Paul D, Caskey Marina, Nussenzweig Michel C
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date. Infection is associated with the development of variable levels of antibodies with neutralizing activity, which can protect against infection in animal models1,2. Antibody levels decrease with time, but, to our knowledge, the nature and quality of the memory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
